Evive Biotech - About the company
Evive Biotech is an unfunded company based in Singapore (Singapore), founded in 2004. It operates as a Developers of biologics for treating oncology and inflammatory disorders. Evive Biotech has not raised any funding yet. The company has 3736 active competitors, including 1229 funded and 866 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Biogen.
Company Details
Evive Biotech is the developer of biologics for treating oncology and inflammatory disorders. The company develops a portfolio of novel drugs by using its two proprietary technology platforms, DiKine and ITab. The pipeline products are in phase 3 of preclinical research and based on G-CSF fusion protein. The flagship products are A337 (phase 1) for solid tumors, A3109 (phase 1) for B-cell leukemia among others.
- Website
- www.evivebiotech.com
- Email ID
- *****@evivebiotech.com
- Phone Number
- +65 **********
- Registered Address
- BEACH ROAD, Singapore, 189720
Key Metrics
Founded Year
2004
Location
Singapore, Singapore
Stage
Unfunded
Ranked
1890th among 3736 active competitors
Employee Count
35 as on Aug 31, 2026
Similar Companies
Legal entities associated with Evive Biotech
Evive Biotech is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD. UEN: 202024734N , Singapore, Active | Aug 18, 2020 | - | - |
Sign up to download Evive Biotech's company profile
Evive Biotech's funding and investors
Evive Biotech has not raised any funding rounds yet.
Evive Biotech's founders and board of directors
Founder? Claim ProfileEvive Biotech's employee count trend
Evive Biotech has 35 employees as of Aug 26. Here is Evive Biotech's employee count trend over the years:
Uncover Evive Biotech's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Evive Biotech's Competitors and alternates
Top competitors of Evive Biotech include Jazz Pharmaceuticals, BeiGene and Biogen. Here is the list of Top 10 competitors of Evive Biotech, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 81/100 | |
2nd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 81/100 | |
3rd |  Biogen 1978, Cambridge (United States), Public | Developer of therapies for neurodegenerative and immunology disorders | $80M | 78/100 | |
4th | Developer of antibody-based drugs to treat autoimmune diseases and cancer | $61.9M | 76/100 | ||
5th | Kite Pharma 2009, Los Angeles (United States), Acquired | Developer of cancer immunotherapy products using genetic engineering | $97.7M | 76/100 | |
6th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
7th |  Elicio 2012, Cambridge (United States), Public | Developer of vaccines for treating cancer | $47.4M | 72/100 | |
8th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 72/100 | ||
9th |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 72/100 | |
10th |  Abcellera Biologics 2012, Vancouver (Canada), Public | AI-enabled platform for antibodies discovery | $115M | 71/100 | |
1890th |  Evive Biotech 2004, Singapore (Singapore), Unfunded | Developers of biologics for treating oncology and inflammatory disorders | - | - | 31/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Evive Biotech's competitors? Click here to see the top ones
Evive Biotech's Investments and acquisitions
Evive Biotech has made no investments or acquisitions yet.
Reports related to Evive Biotech
Here is the latest report on Evive Biotech's sector:
News related to Evive Biotech
•
Nona Biosciences and Evive enter antibody discovery dealPharmaceutical Technology•Dec 11, 2023•Nona Biosciences, Evive, Evive Biotech
•
Nona Biosciences, Evive Biotech Partner on Antibody DiscoveryContract Pharma•Dec 11, 2023•Evive Biotech, Nona Biosciences
•
Ryzneuta approved for use in ChinaChina Daily•May 10, 2023•Chia Tai Tianqing Pharmaceutical Group, Yifanyy, Evive Biotech
•
Aurobindo Unit, Evive Biotech Ink Licensing Pact To Commercialise Cin Treatment Product In UsIndiatimes•Nov 23, 2022•Aurobindo Pharma, Evive Biotech, Acrotech Biopharma
•
Evive enters license agreement with Acrotech Biopharma to commercialize Ryzneuta in USIndia Infoline•Oct 13, 2022•Acrotech Biopharma, Evive Biotech
•
Tianmaiyuan and completed iTAb™ spin-off and A-round financingBusiness Wire•Dec 01, 2021•ITabMed, Evive Biotech, ITBMed
•
Evive Biotech Submits Biologics License Application To Us Fda For Ryzneuta™Pipelinereview•Mar 31, 2021•Evive Biotech
•
Evive Biotech meets primary and secondary endpoints in global Phase III clinical trial for their novel chemotherapy-induced neutropenia treatmentPipelinereview•Jul 08, 2020•Evive Biotech
•
Evive Biotech unveiled as the new corporate brand for Generon BiomedBioSpectrum Asia•Jun 24, 2020•Evive Biotech
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Evive Biotech
Explore our recently published companies
- Uchc - Farmington based, Unfunded company
- Lambton College - Sarnia based, 1967 founded, Unfunded company
- Karel de Grote Hogeschool - Antwerp based, 1995 founded, Funding Raised company
- ISU - United States based, 1901 founded, Funding Raised company
- Ohio University - United States based, 1804 founded, Funding Raised company
- Iifahealthcare - Unfunded company
